Prostate Cancer UK is urging the government to update NHS guidelines so that GPs can proactively start having conversations ...

Prostate cancer waiting times could be radically cut by an 'extremely encouraging' 20 minute test, scientists have revealed.

Vir Biotechnology posts encouraging initial data from phase I studies evaluating VIR-5818 and VIR-5500 in heavily pretreated patients with various solid tumors.

Scientists at Heriot Watt University developed a cost-effective technique for faster, more accurate prostate cancer detection ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

As robotic techniques continue to evolve, these surgical procedures hold great potential for further transforming cancer treatment and enhancing the quality of care for patients ...

A recent study published on December 19, 2024, in the ExRNA journal highlights research from the Novosibirsk Institute of ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased their price target to $20 from $10. The ...

Morgan Stanley upgraded Vir Biotechnology (NASDAQ:VIR) to Overweight from Equal Weight on Thursday after the cancer drug ...

In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...

Prince William made rare personal comments about his wife Kate Middleton in honor of her 43rd birthday. See the sweet tribute ...

New imaging technique has shown that many cases of prostate cancer may be more advanced than conventional imaging suggests. Read on!